19-32879255-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_032816.5(CEP89):āc.2259T>Gā(p.Val753=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.321 in 1,613,506 control chromosomes in the GnomAD database, including 89,618 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.25 ( 5534 hom., cov: 33)
Exomes š: 0.33 ( 84084 hom. )
Consequence
CEP89
NM_032816.5 synonymous
NM_032816.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.716
Genes affected
CEP89 (HGNC:25907): (centrosomal protein 89) Involved in non-motile cilium assembly. Acts upstream of or within cilium assembly. Located in several cellular components, including cytosol; microtubule cytoskeleton; and non-motile cilium. Part of ciliary transition fiber. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 19-32879255-A-C is Benign according to our data. Variant chr19-32879255-A-C is described in ClinVar as [Benign]. Clinvar id is 1599009.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.716 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.349 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP89 | NM_032816.5 | c.2259T>G | p.Val753= | synonymous_variant | 19/19 | ENST00000305768.10 | |
CEP89 | XM_005259344.4 | c.2187T>G | p.Val729= | synonymous_variant | 19/19 | ||
CEP89 | XM_047439562.1 | c.1518T>G | p.Val506= | synonymous_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP89 | ENST00000305768.10 | c.2259T>G | p.Val753= | synonymous_variant | 19/19 | 1 | NM_032816.5 | P3 | |
CEP89 | ENST00000586984.6 | c.*868T>G | 3_prime_UTR_variant, NMD_transcript_variant | 18/18 | 1 | ||||
CEP89 | ENST00000591698.5 | c.*1593T>G | 3_prime_UTR_variant, NMD_transcript_variant | 18/18 | 2 |
Frequencies
GnomAD3 genomes AF: 0.247 AC: 37631AN: 152100Hom.: 5537 Cov.: 33
GnomAD3 genomes
AF:
AC:
37631
AN:
152100
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.261 AC: 65690AN: 251424Hom.: 9839 AF XY: 0.268 AC XY: 36460AN XY: 135890
GnomAD3 exomes
AF:
AC:
65690
AN:
251424
Hom.:
AF XY:
AC XY:
36460
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.329 AC: 480818AN: 1461288Hom.: 84084 Cov.: 36 AF XY: 0.326 AC XY: 237048AN XY: 726972
GnomAD4 exome
AF:
AC:
480818
AN:
1461288
Hom.:
Cov.:
36
AF XY:
AC XY:
237048
AN XY:
726972
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.247 AC: 37627AN: 152218Hom.: 5534 Cov.: 33 AF XY: 0.241 AC XY: 17953AN XY: 74410
GnomAD4 genome
AF:
AC:
37627
AN:
152218
Hom.:
Cov.:
33
AF XY:
AC XY:
17953
AN XY:
74410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
458
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at